SearchDictionaryMobileLogin

Current management: Management of rheumatic diseases in the era of biological anti-rheumatic drugs.

AuthorsYrjö T Konttinen, Seppo Seitsalo, Matti Lehto, Seppo Santavirta (Affiliation: Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland. yrjo.konttinen at helsinki.fi)
JournalActa orthopaedica (Acta Orthop) Vol. 76 Issue 5 Pg. 614-9 (Oct 2005) ISSN: 1745-3674 Sweden
PMID16263606 (Publication Type: Journal Article, Review)
Chemical References
  • Anti-Inflammatory Agents, Non-Steroidal
  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • IL1RN protein, human
  • Immunoglobulin G
  • Interleukin 1 Receptor Antagonist Protein
  • Receptors, Tumor Necrosis Factor
  • Sialoglycoproteins
  • adalimumab
  • infliximab
  • TNFR-Fc fusion protein
Topics
  • Anti-Inflammatory Agents, Non-Steroidal (therapeutic use)
  • Antibodies, Monoclonal (therapeutic use)
  • Antirheumatic Agents (therapeutic use)
  • Arthritis, Rheumatoid (complications, diagnosis, drug therapy, microbiology)
  • Drug Therapy, Combination
  • Humans
  • Immunoglobulin G (therapeutic use)
  • Interleukin 1 Receptor Antagonist Protein
  • Opportunistic Infections (complications, drug therapy)
  • Practice Guidelines as Topic
  • Receptors, Tumor Necrosis Factor (therapeutic use)
  • Sialoglycoproteins (therapeutic use)